Peter Gray
Director/Board Member presso JAZZ PHARMACEUTICALS PLC
Patrimonio netto: 2 M $ in data 31/03/2024
Profilo
Peter Gray is currently the Chairman at Teckro Ltd.
since 2015.
He is also currently serving as the Director at Jazz Pharmaceuticals, Inc. since 2013 and as the Independent Director at Jazz Pharmaceuticals Plc since 2013.
Previously, he held the position of Vice Chairman at ICON plc from 2011 to 2012.
He also served as the Non-Executive Chairman at UDG Healthcare Ltd.
(Dublin) from 2012 to 2020.
Additionally, he worked as a Senior Financial Officer at Elan Corp.
Plc from 1983 to 1989.
Mr. Gray obtained his graduate degree from Trinity College Dublin in 1977.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
14/08/2023 | 16 068 ( 0.03% ) | 2 M $ | 31/03/2024 |
Posizioni attive di Peter Gray
Società | Posizione | Inizio |
---|---|---|
JAZZ PHARMACEUTICALS PLC | Director/Board Member | 08/05/2013 |
Teckro Ltd.
Teckro Ltd. Packaged SoftwareTechnology Services Teckro Ltd. owns and operates a mobile digital answers engine. It has developed a software platform that streamlines clinical trials in pharmaceutical industries. The firm offers artificial intelligence platform that returns actionable information automatically. The company was founded by Nigel Hughes, Jacek Skrzypiec and Gary Hughes in 2015 and is headquartered in Limerick. Ireland. | Chairman | 01/08/2015 |
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Director/Board Member | 01/05/2013 |
Precedenti posizioni note di Peter Gray
Società | Posizione | Fine |
---|---|---|
UDG HEALTHCARE PLC | Chairman | 01/09/2020 |
ICON PUBLIC LIMITED COMPANY | Chief Executive Officer | 01/09/2011 |
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | Corporate Officer/Principal | 01/11/1989 |
ABZENA PLC | Director/Board Member | - |
Formazione di Peter Gray
Trinity College Dublin | Graduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
ICON PUBLIC LIMITED COMPANY | Commercial Services |
JAZZ PHARMACEUTICALS PLC | Health Technology |
Aziende private | 5 |
---|---|
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | Health Technology |
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Health Technology |
UDG Healthcare Ltd. (Dublin)
UDG Healthcare Ltd. (Dublin) Miscellaneous Commercial ServicesCommercial Services UDG Healthcare Plc engages in the supply and distribution of pharmaceutical and medical products. It operates through the following segments: Ashfield, Sharp, and Aquilant. The Ashfield segment provides commercialization services for the pharmaceutical and healthcare industry. The Sharp segment offers contract packaging and clinical trial packaging services. The Aquilant segment involves. outsourced sales, marketing, distribution, and engineering services to the medical and scientific sectors. The company was founded in 1948 and is headquartered in Dublin, Ireland. | Commercial Services |
Abzena Ltd.
Abzena Ltd. BiotechnologyHealth Technology Abzena Ltd. engages in the provision of proprietary technologies and complementary services to enable the development and manufacture of biopharmaceutical products. It offers antibody discover and candidate screening, immunology and immunogenicity assessment, antibody and protein engineering, bio conjugation, custom synthesis of cytotoxic payloads, reagents, and other small molecules, manufacture of payload linkers, development of manufacturing cell lines, and manufacture of biopharmaceuticals. The company was founded by Sunil Shaunak in 2001 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Teckro Ltd.
Teckro Ltd. Packaged SoftwareTechnology Services Teckro Ltd. owns and operates a mobile digital answers engine. It has developed a software platform that streamlines clinical trials in pharmaceutical industries. The firm offers artificial intelligence platform that returns actionable information automatically. The company was founded by Nigel Hughes, Jacek Skrzypiec and Gary Hughes in 2015 and is headquartered in Limerick. Ireland. | Technology Services |
- Borsa valori
- Insiders
- Peter Gray